Experience
GlaxoSmithKline
Synthon Pharmaceuticals, Inc.
Represented GlaxoSmithKline in ANDA suit involving multibillion dollar antidepressant Paxil®, with consent judgment and injunction issuing on behalf of GlaxoSmithKline based on settlement agreement.
GlaxoSmithKline v. Synthon Pharmaceuticals, Inc., 1:00-cv-01179, M.D.N.C., Judge Beaty
Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.
Eli Lilly and Co.; ICOS
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Apotex Inc. v. Senju Pharmaceutical
Senju Pharmaceuticals Co. Ltd.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Medicis Pharmaceutical Corp. v. Taro Pharmaceuticals USA, Inc.
Medicis Pharmaceutical Corp.
AstraZeneca Pharmaceuticals LP, Shionogi Co. v. Watson Pharmaceuticals, Inc.
AstraZeneca Pharmaceuticals LP; Shionogi Co.
Pronova Biopharma Norge AS v. Teva Pharmaceuticals USA, Inc.
Pronova Biopharma Norge AS
Classen Immunotherapies, Inc. v. Elan Pharmaceuticals, Inc.
Elan Pharmaceuticals, Inc.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.